On 28 August 2026, a division bench of the Bombay High Court’s Nagpur bench directed the Maharashtra government to file a detailed affidavit within a week on the rules and procedure for identifying illegal pathology laboratories. The order compels the state to articulate the specific criteria and sanctions applicable to laboratories that operate without qualified medical supervision. Diagnostic service providers in Maharashtra now face a defined enforcement regime that could lead to suspension or cancellation of licences for non‑compliance. The ruling also clarifies the scope of the supervisory requirement under the Clinical Establishments Act.

Full News Breakdown

The petition, filed by a Yavatmal social worker, alleged that numerous pathology laboratories in the state were being run by technicians instead of qualified doctors, endangering patients through inaccurate reports. The government argued that a new regulatory framework was in the works but could not produce the requested details, prompting the bench to intervene.

• Case Name: Digambar Pajgade v. State of Maharashtra

• Court: Bombay High Court, Nagpur bench

• Bench: Justices Anil Kilor and Rajnish Vyas

• Date: 28 August 2026

• Statutes Cited: Clinical Establishments (Registration and Regulation) Act, 2010

• Primary Legal Issue: Adequacy of the existing regulatory framework for illegal pathology laboratories

• Petitioner Arguments: Laboratories operated by DMLT/CMLT technicians; risk to patients from inaccurate reports

• Respondent Arguments: Government claimed a new regulatory framework was being prepared but provided no details

• Court's Reasoning: The government’s response was deemed insufficient to satisfy the statutory duty of supervision, necessitating a sworn affidavit that spells out the enforcement mechanism

• Ratio Decidendi: The state must define the identification criteria and punitive measures for labs lacking qualified medical oversight, as the statutory scheme demands concrete rules for enforcement

• Operative Order: File a detailed affidavit within one week explaining the rules, identification procedure, and actions that can be taken against illegal labs

• Practical Outcome: The matter will return for further consideration after the affidavit is filed

How Does This Affect You?

Earlier, the absence of a clear procedural rule left providers uncertain about the legal consequences of operating without a qualified supervisor. The High Court’s mandate now forces Maharashtra to set out the exact parameters and penalties in a sworn statement. Consequently, compliance obligations become quantifiable, making it easier for regulators to act and for providers to gauge the risk of non‑compliance. This new certainty informs the advice we give to lawyers, students, and businesses in the sections that follow.

For Lawyers & Advocates

• Review and update each client’s registration under the Clinical Establishments Act to ensure the supervising doctor’s qualifications are recorded, because the affidavit will likely be used to verify compliance during inspections.

• Draft or revise internal standard operating procedures to include a checklist of required qualifications for pathologists and to maintain signed declarations, as the court’s demand for detailed criteria will make inspections evidence‑based.

• Prepare a template affidavit response for clients who may receive a state‑issued show‑cause notice, referencing the statutory provision that makes qualified supervision mandatory and pre‑empting procedural objections.

• Advise clients that any pending expansion or new laboratory opening must obtain prior clearance confirming qualified medical supervision, since the forthcoming state framework may impose pre‑emptive approval before licence issuance.

• Flag the residual risk that the court did not cap the scope of sanctions, allowing the state to impose penalties beyond those enumerated in the Act; be ready to challenge over‑broad penalties on the ground of proportionality and procedural fairness.

For Law Students

The case illustrates how courts can compel an administration to flesh out the procedural content of a statutory duty. It pivots on the doctrine of statutory duty and the requirement that reasonable rules be framed for enforcement.

The decision is particularly relevant for the study of:

• Administrative Law – duty of state to frame executable rules

• Health Law – supervision of diagnostic labs under the Clinical Establishments Act

• Public Interest Litigation – use of PIL to enforce regulatory compliance

• Constitutional Law – principle of reasonable governance under Article 14

• Evidence Law – reliance on affidavits to demonstrate statutory compliance

Comparable cases such as M.C. Mehta v. Union of India (1987) and State of Karnataka v. Union of India (2015) show how the Supreme Court expects legislatures and executives to translate statutory mandates into actionable rules, highlighting the judicial check on vague regulatory schemes.

For Businesses

• Diagnostic lab chains must verify that every facility’s licence under the Clinical Establishments Act includes a documented supervising pathologist; failure may trigger licence suspension or cancellation.

• Hospital groups with in‑house labs need to revise compliance audit reports to capture individual staff qualifications, lest they face regulatory notices under the new framework.

• CFOs and board members should allocate budget for periodic third‑party verification of supervision compliance before the state releases its detailed rules, to avoid unexpected financial penalties.

• Multi‑state healthcare providers should harmonise internal policies with Maharashtra’s impending criteria, because divergent state‑level standards could create fragmented compliance obligations across the country.

Key Takeaways

• The law now obliges the Maharashtra government to specify the exact criteria and sanctions for operating a pathology lab without a qualified medical supervisor.

• Legal practitioners must verify and document the supervising doctor’s credentials in all client lab registrations and be ready to produce affidavits when demanded.

• Regulators can now enforce suspension, cancellation, or monetary penalties based on the prescribed criteria, whereas previously they lacked a defined enforcement tool.

• Watch for the Maharashtra Health Department’s detailed regulatory framework, expected to be tabled within weeks of the affidavit filing.

• In‑house counsel should audit all pathology lab compliance files and submit any missing qualification evidence before the September 4, 2026 affidavit deadline.

Source: HC Seeks Clarity on Action Against Illegal Pathology Labs